Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 212-222, April 2005

The next generation of diabetic nephropathy therapies: An update

  • Mark E. Williams

      Affiliations

    • Joslin Diabetes Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Mark E. Williams, MD, Renal Unit, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215.
    • ,
  • Katherine R. Tuttle

      Affiliations

    • The Heart Institute of Spokane, Spokane, WA, USA, and Sacred Heart Medical Center, Spokane, WA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Mark E. Williams has served as a consultant for Biostratum, Inc., and Katherine R. Tuttle has served as a consultant for Eli Lilly and Co.

PII: S1548-5595(05)00035-2

doi:10.1053/j.ackd.2005.01.011

Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 212-222, April 2005

Article Tools

* Image Usage & Resolution